Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screening - Medpage Today
6/30/2022 12:00:00 AM2 years 10 months ago
by Zaina Hamza
by Zaina Hamza
Hepatocellular carcinoma risk persisted after direct-acting antivirals
Hepatocellular carcinoma (HCC) risk declined but remained high enough for screening in the first 7 years for some patients cured of their hepatitis C virus infections with direct-acting antivirals, a… [+3899 chars]
full article...